Company:Cipla

Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014
2
626

2013

2012

2011

2010

10,100.39

8,279.33

7,020.71

6,323.84

5,624.91

1,416.66

1,551.06

1,141.30

967.13

1,082.59

160.58

160.58

160.58

160.58

160.58

9,939.35

8,858.10

7,478.35

6,505.55

5,741.02

10,099.93

9,018.68

7,638.93

6,666.13

5,901.60

1,228.34

966.93

13.46

540.98

5.07

14.03%
17.20%
14.94%
14.51%
18.34%
0.1216187 0.107214 0.001762 0.081154 0.000859
52,081.35

CAGR

15.76%
6.95%

Company: Lupin
Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014
2
1870.15

2013

2012

2011

2010

8,939.38

7,122.51

5,384.83

4,494.88

3,690.09

2,324.22

1,260.43

804.37

809.98

648.93

89.68

89.51

89.33

89.24

88.94

6,889.36

4,757.20

3,645.08

3,063.42

2,441.61

6,979.04

4,846.71

3,734.41

3,152.66

2,530.55

139.4

555.29

992.65

979.46

906.81

33.30%
26.01%
21.54%
25.69%
25.64%
0.019974 0.114571 0.265812 0.310677 0.358345
84,193.70

CAGR

24.76%
37.57%

Company:Aurobindo Pharma
Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014
1
1415.35

2013

2012

2011

2010

8,099.79

5,855.32

4,627.40

4,384.80

3,604.27

1,169.07

291.4

-124.14

563.06

563.08

29.15

29.12

29.11

29.11

27.86

3,721.00

2,576.64

2,310.54

2,415.72

1,801.22

3,750.15

2,605.76

2,339.65

2,444.83

1,829.08

3,633.92

3,384.38

2,572.84

2,414.35

2,154.56

31.17%
11.18%
-5.31%
23.03%
30.78%
0.969007 1.298807 1.099669 0.987533 1.177947
42,413.35

CAGR

22.44%
20.04%

Company: Cadila Healthcare

Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014
5
1838

2013

2012

2011

2010

7,224.00

6,357.70

4,827.40

4,197.20

3,626.90

836.2

689.9

681.2

736.1

528.9

102.4

102.4

102.4

102.4

68.2

3,336.60

2,842.10

2,474.30

2,025.10

1,516.40

3,439.00

2,944.50

2,576.70

2,127.50

1,584.60

2,264.60

2,683.10

2,009.40

1,079.80

1,056.70

24.32%
23.43%
26.44%
34.60%
33.38%
0.658505 0.911224 0.779835 0.507544 0.666856
38,677.00

CAGR

18.80%
12.13%

Company: Dr Reddys Laboratories

Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014
5
3547.7

2013

2012

2011

2010

13,359.10

11,895.60

9,814.50

7,496.90

6,988.60

1,963.20

1,526.80

1,300.90

998.9

351.5

85.1

84.9

84.8

84.6

84.4

7,780.10

6,284.20

4,904.20

3,947.30

3,692.40

7,865.20

6,369.10

4,989.00

4,031.90

3,776.80

4,136.20

3,164.50

3,230.70

2,369.10

1,484.00

24.96%
23.97%
26.08%
24.77%
9.31%
0.525886 0.496852 0.647565 0.587589 0.392925
63,825.33

CAGR

17.58%
53.73%

Company: Jubilant Life Sciences

Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014
1
168.85

2013

2012

2011

2010

5,803.36

5,160.95

4,303.13

3,436.61

3,783.90

137.64

188.78

45.69

227.23

421.95

15.45

15.93

15.93

15.93

15.88

2,611.07

2,478.42

2,313.84

2,156.34

2,173.38

2,626.52

2,494.35

2,329.77

2,172.27

2,189.26

2,904.71

3,387.60

3,606.99

3,924.52

3,172.73

5.24%
7.57%
1.96%
10.46%
19.27%
1.105916 1.358109 1.548217 1.806645 1.449225
3,218.28

CAGR

11.28%
-24.43%

Company: Torrent Pharmaceuticals

Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014
5
1316.45

2013

2012

2011

4,184.72

3,211.14

2,695.92

2,224.57

663.91

434.91

286.3

270.17

84.62

42.31

42.31

42.31

1,817.81

1,379.62

1,151.51

980.1

1,902.43

1,421.93

1,193.82

1,022.41

954.89

579.16

460.18

572.06

34.90%
30.59%
23.98%
26.42%
0.501932 0.407306 0.385468 0.559521
22,455.01

2010 CAGR

1,902.49
231.2
42.31
788.67

830.98
522.3

27.82%
0.628535

21.78%
30.18%

Company: Ipca Laboratories

Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014
2
698.65

2013

2012

2011

2010

3,281.77

2,813.12

2,370.09

1,975.34

1,621.93

478.2

324.6

276.2

262.31

203.54

25.24

25.24

25.23

25.14

25.04

1,934.42

1,528.54

1,228.78

1,026.45

839.84

1,959.66

1,553.78

1,254.01

1,051.59

864.88

437.94

523.35

531.54

530.32

454.01

24.40%
20.89%
22.03%
24.94%
0.223478 0.336824 0.423872 0.504303

23.53%
0.52494

8,664.20

CAGR

19.27%
23.81%

Company: Sun Pharmaceutical Industries

Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014
1
873

2013

2012

2011

16,080.36

11,299.86

8,019.49

5,727.90

3,879.00

3,469.34

3,042.17

1,907.37

207.12

103.56

103.56

103.56

18,317.83

14,886.17

12,132.22

9,379.76

2,489.01

198.21

264.99

365.06

216,915.00

2010 CAGR

3,903.23
1,346.98
103.56
7,725.35
171.15

Company: Divis Laboratories

Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014
2
1854.25

2013

2012

2011

2010

2,532.14

2,144.84

1,864.03

1,311.38

943.96

773.34

602.01

533.26

429.27

340.34

26.55

26.55

26.55

26.52

26.43

2,936.80

2,474.05

2,104.98

1,770.96

1,491.38

17.87

32.61

52.76

23.04

32.85

24,919.54

CAGR

Company:Glenmark Pharma
Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014
1
1018.5

2013

2012

2011

2010

6,005.20

5,012.34

4,020.64

2,949.07

2,480.46

545.6

623

464.31

457.83

331.03

27.12

27.09

27.05

27.03

26.98

2,956.16

2,735.94

1,598.96

1,238.12

2,328.25

3,266.98

2,288.12

1,999.93

2,097.29

1,869.39

29,047.98

CAGR

Company:Biocon
Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014
5
470.1

2013

2012

2011

2010 CAGR

2,877.30

2,485.30

2,086.50

1,806.00

2,317.46

430.8

512.7

338.4

367.5

302.81

100

100

100

100

100

2,926.70

2,594.60

2,172.40

1,932.80

1,656.90

849.7

248.8

257.1

313.2

513.61

9,344.00

Company:Alembic Pharmaceuticals
Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014
2
679

2013

2012

2011

2,056.12

1,863.22

1,520.35

1,466.39

282.72

235.51

165.25

130.13

37.7

37.7

37.7

37.7

846.94

637.87

465.24

357.3

238.5

77.65

140.64

234.32

14,347.95

2010 CAGR

1,192.35
85.39
37.7
259.03
327.9

Company:Cipla
Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014

2013

2012

2011

2010 CAGR

Company:Cipla
Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014

2013

2012

2011

2010 CAGR

Company:Cipla
Particular
Face Value
Current Market Price
M-CAP
Net Sales
PAT
Equity
Reserves & Surplues
Net Worth/ Sh.Funds
Debt
RoE/RoNW= PAT/NW
Debt:Equity
Market Capitalization

2014

2013

2012

2011

2010 CAGR